ankylosing spondylitis
New Indication Granted to Rinvoq for Active Ankylosing Spondylitis
The FDA granted a new indication to upadacitinib for the treatment of adults with active ankylosing spondylitis who ...
MAY 9, 2022
FDA Approves Hadlima Biosimilar for RA, Other Inflammatory Condition
Hadlima was approved for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic ...
AUGUST 27, 2019
Load more